WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

European Consumers Seeking Health and Pharmaceutical Information

Details
Research
14 October 2007
Manhattan ResearchEuropean consumers have been a long-neglected piece of the strategic puzzle for most marketers at health and pharmaceutical companies. Yet signs increasingly point to the degree to which European consumers are, in fact, researching health information and treatment options, and ultimately taking action as a result of those information searches.
Read more ...

Life Science Platform Promotes True Scientific Collaboration

Details
Research
10 October 2007
SyynX Solutions GmbHCollexis (OTCBB: CLXS), a leading developer of high-definition search and discovery software, and their German partner, SyynX Solutions, announced they will preview a new life sciences social networking site to representatives from global book publishing and multimedia companies at the Frankfurt Book Fair in Frankfurt, Germany.
Read more ...

Integrated RSS Management Solution Simplifies Information Management and Delivery

Details
Research
05 October 2007
The Thomson CorporationThomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, announced the launch of Enterprise Alert Manager, an integrated RSS management and collaboration solution designed to simplify information distribution across an organization by allowing for easy deployment while reducing email load and network strain.
Read more ...

European Medicines Agency recommends restricted use of nimesulide-containing medicinal products

Details
Research
30 September 2007
European Medicines Agency (EMEA)Finalising a review of the liver safety of systemic formulations of medicines containing nimesulide, the European Medicines Agency (EMEA) has concluded that the benefits of these medicines outweigh their risks, but that there is a need to limit the duration of use and to restrict their use to ensure that the risk of patients developing liver problems is kept to a minimum.
Read more ...

New EU Project to Develop a Novel Pandemic Influenza Vaccine

Details
Research
28 September 2007
EUInternational experts in the field of human virus research and vaccine development have teamed up to develop a pandemic influenza vaccine. The aim of the EU-funded FluVac project is to conduct research and development (R&D) into a novel pandemic influenza vaccine that could be used as a potential emergency vaccination. The project partners, recently awarded a grant of €3.5 million under the EU's Sixth Framework Programme (FP6), plan to deliver a prototype vaccine within four years.
Read more ...

Launch of a broad public debate on the future of pharmaceuticals for human use in Europe

Details
Research
26 September 2007
EUThe Commission launches a public consultation on the future of pharmaceuticals for human use in Europe. The pharmaceutical sector has been and remains a key strategic sector in Europe. The future of this sector is a crucial matter for the EU.
Read more ...

Scientists discover how brain regulates fat metabolism

Details
Research
25 September 2007
Scientists have discovered the brain region which controls whether excess energy should be stored as fat or burned in our muscles. The researchers hope that their findings will lead to the development of new treatments for obesity. The work, which was partly funded by the EU, is published in the Journal of Clinical Investigation.
Read more ...

More Pharma News ...

  1. New Awards Program Focused on Cardiovascular Risk in Patients with Diabetes
  2. ASCO Journals to be accessible through SIMID® S.M.I.L.E.
  3. The Bill & Melinda Gates Foundation New Grants to Fight Tuberculosis Epidemic
  4. Spending on Cancer Research in Europe Rising
  5. semgine GmbH - Product release of the semgine sciPlorer® 1.3
  6. ePharma Physician® Research Study and Advisory Service Focused on Physician IT Adoption
  7. Advances in Functional Proteomics Spell Speedier Drug Discovery
  • Start
  • Prev
  • 294
  • 295
  • 296
  • 297
  • 298
  • 299
  • 300
  • 301
  • 302
  • 303
  • Next
  • End

Business & Industry

  • Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe

Research & Development

  • New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
  • Research identifies, exploits vulnerability in certain high-risk cancers
  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Research
  4. Vaccine-induced immune response to omicron wanes substantially over time

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.